AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Analysts Predict 11% Upside for Dimensional US Vector Equity ETF (DXUV)
ByAinvest
Friday, Sep 5, 2025 8:13 am ET1min read
Analysts predict an 11% upside for the Dimensional US Vector Equity ETF (DXUV) based on its underlying holdings, with the ETF currently trading at $57.91 per unit and an average analyst target price of $64.40 per unit. Three of DXUV's underlying holdings with notable upside to their analyst target prices are Mastech Digital Inc (MHH), Escalade, Inc. (ESCA), and Electromed, Inc. (ELMD).
Analysts have predicted an 11% upside for the Dimensional US Vector Equity ETF (DXUV), with the ETF currently trading at $57.91 per unit and an average analyst target price of $64.40 per unit. The ETF, which is managed by Dimensional Fund Advisors LP, aims to invest at least 80% of its net assets in equity securities of U.S. companies [1].Three of DXUV's underlying holdings are expected to contribute significantly to this potential upside. Mastech Digital Inc (MHH), Escalade, Inc. (ESCA), and Electromed, Inc. (ELMD) are among the notable holdings with notable upside to their analyst target prices.
Mastech Digital Inc (MHH) is a technology services company that offers a range of digital transformation solutions. The company has been performing well, with analysts predicting a significant increase in its stock price. Escalade, Inc. (ESCA) is a luxury vehicle manufacturer that has seen strong demand for its high-end models. Electromed, Inc. (ELMD) is a medical technology company that focuses on developing innovative solutions for various health conditions. The company's pipeline includes promising treatments that modulate lipid-signaling pathways for conditions such as cancer, pain, and neurological disorders [2].
The ETF's performance will be influenced by the overall market conditions and the performance of its underlying holdings. Investors should closely monitor the developments in these companies and the broader market to make informed investment decisions.
References:
[1] https://finance.yahoo.com/quote/DXUV/profile/
[2] https://www.ainvest.com/news/waning-ev-demand-automaker-valuations-strategic-production-cuts-reshape-landscape-2509/
[3] https://www.investing.com/news/company-news/artelo-biosciences-prices-3-million-public-offering-of-common-stock-93CH-4224356
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet